Chicago Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.81M | Sell |
75,196
-8,371
| -10% | -$219K | 0.26% | 88 |
|
|
2026
Q1 | $2.35M | Buy |
83,567
+4,650
| +6% | +$124K | 0.38% | 61 |
|
|
2025
Q4 | $1.97M | Buy |
78,917
+17,081
| +28% | +$431K | 0.31% | 72 |
|
|
2025
Q3 | $1.58M | Buy |
61,836
+2,522
| +4% | +$62.2K | 0.22% | 89 |
|
|
2025
Q2 | $1.44M | Buy |
59,314
+17,250
| +41% | +$402K | 0.2% | 99 |
|
|
2025
Q1 | $1.07M | Buy |
42,064
+315
| +0.8% | +$8.24K | 0.19% | 116 |
|
|
2024
Q4 | $1.11M | Buy |
41,749
+4,400
| +12% | +$119K | 0.2% | 111 |
|
|
2024
Q3 | $1.08M | Sell |
37,349
-33
| -0.1% | -$963 | 0.19% | 118 |
|
|
2024
Q2 | $1.05M | Sell |
37,382
-4,448
| -11% | -$122K | 0.21% | 103 |
|
|
2024
Q1 | $1.16M | Buy |
41,830
+7,400
| +21% | +$205K | 0.24% | 100 |
|
|
2023
Q4 | $991K | Sell |
34,430
-18,632
| -35% | -$563K | 0.22% | 110 |
|
|
2023
Q3 | $1.76M | Sell |
53,062
-1,455
| -3% | -$51.5K | 0.44% | 59 |
|
|
2023
Q2 | $2M | Sell |
54,517
-1,560
| -3% | -$60.7K | 0.48% | 51 |
|
|
2023
Q1 | $2.29M | Sell |
56,077
-18,188
| -24% | -$786K | 0.57% | 45 |
|
|
2022
Q4 | $3.81M | Sell |
74,265
-9,373
| -11% | -$449K | 0.95% | 20 |
|
|
2022
Q3 | $3.66M | Sell |
83,638
-2,766
| -3% | -$134K | 0.95% | 21 |
|
|
2022
Q2 | $4.53M | Buy |
86,404
+1,831
| +2% | +$93.3K | 1.14% | 14 |
|
|
2022
Q1 | $4.38M | Sell |
84,573
-3,405
| -4% | -$177K | 0.94% | 23 |
|
|
2021
Q4 | $5.2M | Buy |
87,978
+7,190
| +9% | +$356K | 1.03% | 14 |
|
|
2021
Q3 | $3.47M | Buy |
80,788
+6,656
| +9% | +$295K | 0.76% | 32 |
|
|
2021
Q2 | $2.9M | Buy |
74,132
+12,413
| +20% | +$483K | 0.69% | 40 |
|
|
2021
Q1 | $2.24M | Buy |
61,719
+3,142
| +5% | +$112K | 0.77% | 43 |
|
|
2020
Q4 | $2.16M | Sell |
58,577
-275
| -0.5% | -$10.1K | 0.74% | 42 |
|
|
2020
Q3 | $2.05M | Buy |
58,852
+1,046
| +2% | +$36.7K | 0.85% | 35 |
|
|
2020
Q2 | $1.79M | Sell |
57,806
-335
| -0.6% | -$11.4K | 0.79% | 37 |
|
|
2020
Q1 | $1.8M | Sell |
58,141
-1,019
| -2% | -$34.7K | 0.91% | 32 |
|
|
2019
Q4 | $2.2M | Sell |
59,160
-2,172
| -4% | -$77.4K | 0.89% | 35 |
|
|
2019
Q3 | $2.09M | Sell |
61,332
-247
| -0.4% | -$8.98K | 0.88% | 34 |
|
|
2019
Q2 | $2.53K | Sell |
61,579
-5,868
| -9% | -$233K | 1.08% | 31 |
|
|
2019
Q1 | $2.72K | Sell |
67,447
-2,212
| -3% | -$88.6K | 1.17% | 27 |
|
|
2018
Q4 | $2.88K | Sell |
69,659
-1,111
| -2% | -$46.1K | 1.37% | 25 |
|
|
2018
Q3 | $2.96M | Buy |
70,770
+812
| +1% | +$31.3K | 1.18% | 27 |
|
|
2018
Q2 | $2.41M | Sell |
69,958
-726
| -1% | -$24.8K | 1.03% | 35 |
|
|
2018
Q1 | $2.38M | Sell |
70,684
-1,021
| -1% | -$35.1K | 1.02% | 36 |
|
|
2017
Q4 | $2.46M | Hold |
71,705
| – | – | 0.98% | 39 |
|
|
2017
Q3 | $2.43K | Buy |
71,705
+1,338
| +2% | +$43K | 1.02% | 37 |
|
|
2017
Q2 | $2.24K | Sell |
70,367
-980
| -1% | -$30.9K | 1% | 38 |
|
|
2017
Q1 | $2.32K | Sell |
71,347
-1,637
| -2% | -$51.6K | 1.02% | 34 |
|
|
2016
Q4 | $2.25M | Sell |
72,984
-362
| -0.5% | -$11.1K | 0.98% | 41 |
|
|
2016
Q3 | $2.36M | Sell |
73,346
-1,176
| -2% | -$39.3K | 1.03% | 32 |
|
|
2016
Q2 | $2.49M | Hold |
74,522
| – | – | 1.02% | 31 |
|
|
2016
Q1 | $2.1M | Sell |
74,522
-6,903
| -8% | -$197K | 0.87% | 42 |
|
|
2015
Q4 | $2.49M | Sell |
81,425
-4,948
| -6% | -$156K | 0.97% | 30 |
|
|
2015
Q3 | $2.57M | Sell |
86,373
-4,641
| -5% | -$149K | 0.99% | 31 |
|
|
2015
Q2 | $2.9M | Sell |
91,014
-3,233
| -3% | -$105K | 1.02% | 29 |
|
|
2015
Q1 | $3.11M | Buy |
+94,247
| New | +$3M | 1.07% | 28 |
|
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
Chicago Trust's PFE Position: Q2 2026 in Review
Chicago Trust reduced its Pfizer (PFE) stake by 10% in Q2 2026, selling an estimated $219K and leaving 75,196 shares worth $1.81M. The position accounts for 0.26% of the portfolio, ranked #88.
Chicago Trust first reported a position in PFE in Q1 2015 and has held it in 46 quarters since. The position peaked at $5.2M in Q4 2021. 603 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Chicago Trust held 75,196 shares of Pfizer worth $1.81M as of Q2 2026.
- Chicago Trust sold 8,371 Pfizer shares in Q2 2026, an estimated $219K.
- Pfizer made up 0.26% of Chicago Trust's portfolio in Q2 2026, its #88 holding.
- Chicago Trust first reported a position in Pfizer in Q1 2015 and has held it in 46 quarters since.
- Chicago Trust's Pfizer position peaked at $5.2M in Q4 2021.
- 603 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.